[ad_1]
LONDON: The UK drug regulator said on Thursday (March 11) that British people should continue to receive their COVID-19 vaccines, including the vaccine developed by Oxford and AstraZeneca, after Denmark and some other countries restricted their use.
Denmark suspends use of the AstraZeneca vaccine for two weeks after reports of blood clots in some who have been vaccinated, including one death in Denmark, Danish authorities said.
Norway joined Denmark in stopping the launch of the vaccine after reports of blood clots, while Italy banned a batch of the vaccine after notifications of some serious adverse effects.
READ: Denmark and Norway temporarily suspend COVID injections from AstraZeneca after reports of blood clots
Britain’s Medicines and Healthcare Products Regulatory Agency (MHRA) said the blood clot reported in Denmark was not confirmed to be caused by the vaccine, adding that the Danish suspension was precautionary.
“Blood clots can occur naturally and are not uncommon,” said Phil Bryan, MHRA Vaccine Safety Leader, adding that more than 11 million doses of the vaccine had been administered across the UK and that reports of blood clots were no greater than they would have occurred. naturally.
“We are looking closely at this issue, but the available evidence does not confirm that the vaccine is the cause. People should go for the COVID-19 vaccine when asked.”
Austria earlier in the week stopped a batch of the injection, but the European Medicines Agency said on Wednesday there was no evidence so far linking the AstraZeneca vaccine to disease in two people who received it in Austria.
CHECK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments
Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram
